Product NDC: | 0168-0271 |
Proprietary Name: | Mometasone Furoate |
Non Proprietary Name: | mometasone furoate |
Active Ingredient(s): | 1 mg/g & nbsp; mometasone furoate |
Administration Route(s): | TOPICAL |
Dosage Form(s): | OINTMENT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0168-0271 |
Labeler Name: | E. FOUGERA & CO. , A division of Fougera Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077061 |
Marketing Category: | ANDA |
Start Marketing Date: | 20050328 |
Package NDC: | 0168-0271-46 |
Package Description: | 45 g in 1 TUBE (0168-0271-46) |
NDC Code | 0168-0271-46 |
Proprietary Name | Mometasone Furoate |
Package Description | 45 g in 1 TUBE (0168-0271-46) |
Product NDC | 0168-0271 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | mometasone furoate |
Dosage Form Name | OINTMENT |
Route Name | TOPICAL |
Start Marketing Date | 20050328 |
Marketing Category Name | ANDA |
Labeler Name | E. FOUGERA & CO. , A division of Fougera Pharmaceuticals Inc. |
Substance Name | MOMETASONE FUROATE |
Strength Number | 1 |
Strength Unit | mg/g |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Corticosteroid Hormone Receptor Agonists [MoA] |